These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 35118878)

  • 1. Clinical application of nano-targeting for enhancing chemotherapeutic efficacy and safety in cancer management.
    Phillips MC; Mousa SA
    Nanomedicine (Lond); 2022 Mar; 17(6):405-421. PubMed ID: 35118878
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles in Combating Cancer: Opportunities and Limitations. A Brief Review.
    Pedziwiatr-Werbicka E; Horodecka K; Shcharbin D; Bryszewska M
    Curr Med Chem; 2021; 28(2):346-359. PubMed ID: 32000637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomedicine: Innovative Strategies and Recent Advances in Targeted Cancer Therapy.
    Gautam RK; Mittal P; Goyal R; Dua K; Mishra DK; Sharma S; Singla RK
    Curr Med Chem; 2024; 31(28):4479-4494. PubMed ID: 37828674
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer.
    Vyas K; Rathod M; Patel MM
    Nanomedicine; 2023 Apr; 49():102662. PubMed ID: 36746272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Controlled anti-cancer drug release through advanced nano-drug delivery systems: Static and dynamic targeting strategies.
    Moradi Kashkooli F; Soltani M; Souri M
    J Control Release; 2020 Nov; 327():316-349. PubMed ID: 32800878
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nanotargeted agents: an emerging therapeutic strategy for breast cancer.
    Du M; Ouyang Y; Meng F; Ma Q; Liu H; Zhuang Y; Pang M; Cai T; Cai Y
    Nanomedicine (Lond); 2019 Jul; 14(13):1771-1786. PubMed ID: 31298065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implications of nanotechnology for the treatment of cancer: Recent advances.
    Klochkov SG; Neganova ME; Nikolenko VN; Chen K; Somasundaram SG; Kirkland CE; Aliev G
    Semin Cancer Biol; 2021 Feb; 69():190-199. PubMed ID: 31446004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultrasound-mediated nano drug delivery for treating cancer: Fundamental physics to future directions.
    Moradi Kashkooli F; Jakhmola A; Hornsby TK; Tavakkoli JJ; Kolios MC
    J Control Release; 2023 Mar; 355():552-578. PubMed ID: 36773959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nano-therapeutics: The upcoming nanomedicine to treat cancer.
    Khan H; Shahab U; Alshammari A; Alyahyawi AR; Akasha R; Alharazi T; Ahmad R; Khanam A; Habib S; Kaur K; Ahmad S; Moinuddin
    IUBMB Life; 2024 Aug; 76(8):468-484. PubMed ID: 38440959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Emergence in protein derived nanomedicine as anticancer therapeutics: More than a tour de force.
    Wang Z; Zhi K; Ding Z; Sun Y; Li S; Li M; Pu K; Zou J
    Semin Cancer Biol; 2021 Feb; 69():77-90. PubMed ID: 31962173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective Cancer Management: Inimitable Role of Phytochemical Based Nano- Formulations.
    Upaganlawar A; Polshettiwar S; Raut S; Tagalpallewar A; Pande V
    Curr Drug Metab; 2022; 23(11):869-881. PubMed ID: 36065928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanocarrier-based Drug Delivery System for Cancer Therapeutics: A Review of the Last Decade.
    Sohail M; Guo W; Li Z; Xu H; Zhao F; Chen D; Fu F
    Curr Med Chem; 2021; 28(19):3753-3772. PubMed ID: 33019919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted multifunctional lipid-based nanocarriers for image-guided drug delivery.
    Koning GA; Krijger GC
    Anticancer Agents Med Chem; 2007 Jul; 7(4):425-40. PubMed ID: 17630918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advances in Delivery of Chemotherapeutic Agents for Cancer Treatment.
    Yadav A; Singh S; Sohi H; Dang S
    AAPS PharmSciTech; 2021 Dec; 23(1):25. PubMed ID: 34907501
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions.
    Raj R; Mongia P; Kumar Sahu S; Ram A
    Curr Drug Targets; 2016; 17(2):206-28. PubMed ID: 26201484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific targeting cancer cells with nanoparticles and drug delivery in cancer therapy.
    Raj S; Khurana S; Choudhari R; Kesari KK; Kamal MA; Garg N; Ruokolainen J; Das BC; Kumar D
    Semin Cancer Biol; 2021 Feb; 69():166-177. PubMed ID: 31715247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanomedicine as a putative approach for active targeting of hepatocellular carcinoma.
    Elnaggar MH; Abushouk AI; Hassan AHE; Lamloum HM; Benmelouka A; Moatamed SA; Abd-Elmegeed H; Attia S; Samir A; Amr N; Johar D; Zaky S
    Semin Cancer Biol; 2021 Feb; 69():91-99. PubMed ID: 31421265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multi-functional nanocarriers to overcome tumor drug resistance.
    Jabr-Milane LS; van Vlerken LE; Yadav S; Amiji MM
    Cancer Treat Rev; 2008 Nov; 34(7):592-602. PubMed ID: 18538481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Active targeting schemes for nano-drug delivery systems in osteosarcoma therapeutics.
    Shi P; Cheng Z; Zhao K; Chen Y; Zhang A; Gan W; Zhang Y
    J Nanobiotechnology; 2023 Mar; 21(1):103. PubMed ID: 36944946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.